306 related articles for article (PubMed ID: 23803167)
1. Long-term prognosis after surgical excision of basal cell carcinoma: a single institutional study in Japan.
Takenouchi T; Takatsuka S
J Dermatol; 2013 Sep; 40(9):696-9. PubMed ID: 23803167
[TBL] [Abstract][Full Text] [Related]
2. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
3. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 256 cases of basal cell carcinoma after either one-step or two-step surgery in a Japanese institution.
Goto M; Kai Y; Arakawa S; Oishi M; Ishikawa K; Anzai S; Hatano Y; Okamoto O; Katagiri K; Fujiwara S; Shimizu F; Kato A; Shibuya H; Eshima N; Terashi H
J Dermatol; 2012 Jan; 39(1):68-71. PubMed ID: 21951151
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma in Turkey.
Tiftikcioğlu YO; Karaaslan O; Aksoy HM; Aksoy B; Koçer U
J Dermatol; 2006 Feb; 33(2):91-5. PubMed ID: 16556274
[TBL] [Abstract][Full Text] [Related]
6. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
7. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinomas: do they need to be followed up?
Park AJ; Strick M; Watson JD
J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
[TBL] [Abstract][Full Text] [Related]
9. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
[TBL] [Abstract][Full Text] [Related]
10. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
[TBL] [Abstract][Full Text] [Related]
12. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
13. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
[TBL] [Abstract][Full Text] [Related]
14. Narrow-margin excision is a safe, reliable treatment for well-defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan.
Ito T; Inatomi Y; Nagae K; Nakano-Nakamura M; Nakahara T; Furue M; Uchi H
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1828-31. PubMed ID: 25186070
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
16. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia.
Yap FB
Int J Dermatol; 2010 Feb; 49(2):176-9. PubMed ID: 20465642
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
19. Do basal cell carcinomas recur after complete conventional surgical excision?
Griffiths RW; Suvarna SK; Stone J
Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
[TBL] [Abstract][Full Text] [Related]
20. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
